News

Search:

AHRQ Plans Patient-Based Adverse Event Reporting System

1 Likes

Adverse event reporting could become more widespread under a new system proposed by the Agency for Healthcare Research and Quality (AHRQ).In a 10 September Federal Register posting, the agency, which Read More...

Tags:

Adverse Event

AHRQ

Patient

Patient Safety Events

Reporting

Study

House Budget Draft Eliminates Comparative Effectiveness Research Agencies

0 Likes

Two federal agencies charged with controlling costs by conducting non-binding comparative effectiveness research stand to be eliminated under the latest draft of an appropriations bill in the House of Read More...

Tags:

AHRQ

Appropriations

Bill

CER

House

HTA

PCORI

Senate

AHRQ Looking to Establish Registry of Patient Registries

0 Likes

The US Agency for Healthcare Research and Quality (AHRQ), the federal agency charged with improving how healthcare dollars are spent, is announcing its intention to launch a registry of patient Read More...

Tags:

AHRQ

Clinical Trial

Clinical Trials

Patient Registry

Registries

Registry

RoPR

Study

86% of Adverse Patient Events Go Unreported in Hospitals

0 Likes

The US Department of Health and Human Services’ (DHHS) Officer of the Inspector General (OIG) released a report on Friday, 6 January indicating that six in seven adverse events (AEs) that take place Read More...

Tags:

Adverse Event

AHRQ

CMS

DHHS

OIG

Reporting

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013
Warning Letter to Company Cites Low Supplies of Toilet Paper 15 May 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

AHRQ Plans Patient-Based Adverse Event Reporting System

House Budget Draft Eliminates Comparative Effectiveness Research Agencies

AHRQ Looking to Establish Registry of Patient Registries

86% of Adverse Patient Events Go Unreported in Hospitals

Get RF Today